ALBEGA Medical

Ownership

Private

Therapeutic Areas

Oncology

Stage

Preclinical

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Radiopharmaceuticals

ALBEGA Medical General Information

Developing novel radiopharmaceuticals directed against diseases with high unmet medical need, with lead compound Tetrofosmin for glioma treatment

Contact Information

Website

https://www.albega-medical.com/

Primary Industry

Biotech

Corporate Office

Berlin, Berlin
Germany

Drug Pipeline

No pipeline data available

For full access to ALBEGA Medical's pipeline data

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

ALBEGA Medical Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view ALBEGA Medical's complete valuation and funding history, request access »

ALBEGA Medical Financial Metrics